Table 2.
Current State: “Where We Are” |
Optimal State: “Where We Want to Be” |
Improvement Strategies: “What It Will Take” |
|
---|---|---|---|
Meaningful Stakeholder Partnership | Disconnected from customers; Lab silos | Utilizing team science | Develop partnerships between investigators across the translational spectrum early in design/development |
Small/restrictive samples | Leveraging citizen science | Harness power of public for scientific activities | |
Disconnected from industry | Partnering with private industry | Partner with those primed to bring innovations to market | |
Design Innovations for D&I | Pushing out innovations | Eliciting demand and performance needs from users | Understand user motives and context; demonstrate value added and simplicity |
Researcher-driven development | Engaging in human/user-centered design | Involve diverse group of end-users as partners throughout design/development | |
Efficacy over effectiveness | Implementing robust, context-sensitive innovations | Better packaging of research evidence for translation to practice and policy; focus on pragmatic and adaptive trials to optimize adoption potential | |
Learning Health System | Rigid/narrow use of evidence | Ongoing and efficient review of evidence | Use existing data to add to evidence on intervention impact; conduct rapid reviews; use create–trial–sustain approaches to guide ongoing adaptation |
Static delivery systems | Supporting the use of iterative feedback | Give real-time feedback on key outcomes to providers | |
Resistant to change | Promoting an agile workforce with change-oriented mindset | Train workforce in core concepts that apply across technologies |
D&I, Dissemination and Implementation.